Name	Trilostane
Description	Trilostane (Win 24540) is a synthetic androstane derivative with adrenocortical suppressive properties, reversibly inhibiting 3 beta-hydroxysteroid dehydrogenase delta [5-4] isomerase in the adrenal cortex.
In vitro	In MCF-7, Trilostane affects the transcription of genes involved in cell cycle regulation, cell adhesion and matrix formation.
In vivo	In MCF-7, Trilostane affects the transcription of genes involved in cell cycle regulation, cell adhesion and matrix formation.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 45 mg/mL (136.6 mM) Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : < 1 mg/mL (insoluble or slightly soluble)
Keywords	Win-24540 \| inhibit \| Inhibitor \| Trilostane \| Win24540
Inhibitors Related	Disulfiram \| Methotrexate \| Rotenone \| Mycophenolate Mofetil \| Ribavirin \| 4-Diethylaminobenzaldehyde \| Benzyl alcohol \| Isomalt \| Isoniazid \| Ivosidenib
Related Compound Libraries	Bioactive Compound Library \| Anti-Neurodegenerative Disease Compound Library \| Anti-Cancer Clinical Compound Library \| Drug Repurposing Compound Library \| Inhibitor Library \| FDA-Approved Drug Library \| Anti-Cancer Approved Drug Library \| Bioactive Compounds Library Max \| Anti-Cancer Active Compound Library \| Anti-Cancer Drug Library

Trilostane NEW

Product Introduction